跳至主要内容
临床试验/NCT05725109
NCT05725109已完成不适用

Hepatitis C Disease Management: Diagnosis to Treatment Alerts in CHORUS™

Epividian1 个研究点 分布在 1 个国家目标入组 1,063 人开始时间: 2023年1月16日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Epividian
入组人数
1,063
试验地点
1
主要终点
Prescriptions for HCV treatment

研究概览

简要总结

The objective of this study is to evaluate whether sending alerts to healthcare providers and clinic staff to identify patients with untreated hepatitis C infection can increase the uptake of hepatitis C treatment. A period of time without alerts will be compared to a period of time with alerts.

详细描述

The hepatitis C virus (HCV) is one of the most common bloodborne pathogens in the United States. A large proportion of people with HCV infection progress to chronic HCV infection despite the availability of effective treatment; chronic infection can result in cirrhosis, end-stage liver disease, liver cancer, and liver-related death. HCV infection can be cured most of the time with treatment. The objective of this before and after study is to evaluate whether sending alerts to healthcare providers and clinic staff to identify patients with untreated hepatitis C infection can increase the uptake of HCV treatment. A period of time without alerts will be compared to a period of time with alerts. Healthcare providers and clinic staff will not receive alerts during the before period of the study. Healthcare providers and clinic staff will receive alerts during the after period of the study.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18+ years of age
  • In care at an AIDS Healthcare Foundation Healthcare Center
  • Active, untreated HCV infection

排除标准

  • <18 years of age
  • Patients with active HCV infection who have a current prescription for HCV treatment

结局指标

主要结局

Prescriptions for HCV treatment

时间窗: End of follow-up, up to 9 months

Proportion of patients who are prescribed HCV treatment over follow-up, out of patients with a completed visit over follow-up.

次要结局

  • HCV RNA viral load tests(End of follow-up, up to 9 months)

研究者

发起方
Epividian
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Hepatitis C Diagnosis to Treatment Management | 临床试验